Loading...
•
Dec 31, 2025
agilon health Q4 2025 Earnings Report
agilon health Q4 2025 Earnings Report
Key Takeaways
agilon health reported a challenging fourth quarter with a net loss of $189 million and a 3% revenue increase to $1.57 billion. The company faced elevated medical cost trends and negative medical margins, but highlighted transformation initiatives aimed at achieving breakeven Adjusted EBITDA in 2026.
Total revenue increased 3% year-over-year to $1.57 billion in Q4 2025.
Net loss widened significantly to $189 million compared to $106 million in the prior year quarter.
Medical margin turned negative at -$74 million due to elevated medical cost trends reserved at 7.4%.
Total members on the platform decreased 5% to 625,000 following strategic market exits.
Revenue by Segment
Forward Guidance
agilon health expects 2026 to be a year of material improvement, targeting breakeven Adjusted EBITDA at the midpoint of guidance.
Positive Outlook
- Expected breakeven Adjusted EBITDA midpoint for FY 2026.
- Anticipated Medical Margin between $300 million and $350 million for FY 2026.
- Execution of $35 million in operating expense reductions.
- Part D exposure reduced to less than 15% of membership.
- Momentum from transformation initiatives strengthening the business model.
Challenges Ahead
- Total membership expected to decline to 525,000-540,000 due to market exits.
- Medical cost trend expected to remain elevated at 7.5% gross.
- Impact of payor contract exits affecting approximately 50,000 members.
- Total revenues projected to decrease to $5.41 billion - $5.58 billion for FY 2026.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...